Skip to main content
. 2021 Jun 11;12:665407. doi: 10.3389/fimmu.2021.665407

Figure 4.

Figure 4

Validation of the prognostic value of the key immune-related gene signature in GSE74777. (A) The distribution of risk score and survival status. (B) Distribution of specific gene expression based on risk score. (C) Comparison of overall survival of all patients with early stage LUSC between high risk and low risk. (D, E) Kaplan–Meier curves of patients with stage I and stage II LUSC based on risk score.